Codebreak 200: A Phase Iii Multicenter Study Of Sotorasib (Amg 510), A Kras(G12c) Inhibitor, Versus Docetaxel In Patients With Previously Treated Advanced Non-Small Cell Lung Cancer (Nsclc) Harboring Kras P.G12c Mutation
ANNALS OF ONCOLOGY（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要